Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simvastatin Addition for Patients With Recent-onset Schizophrenia

NCT01999309 is registered in ClinicalTrials.gov with Iris Sommer as lead sponsor.

NCT NCT01999309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simvastatin Addition for Patients With Recent-onset Schizophrenia
Lead sponsor
Iris Sommer
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
December 19, 2019
Enrollment
121 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis nos, schizoaffective disorder, schizophrenia, schizophreniform disorder